Infectotrimet 50 Saft

Trimethoprim, the active ingredient in Infectotrimet 50 Saft, is an antibiotic presented as a syrup for oral use. It treats urinary tract infections and is used in patients requiring antibacterial therapy.

GNH USA supplies Infectotrimet 50 Saft as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Trimethoprim is an antibacterial agent that works against susceptible urinary pathogens and related infections.

- Uncomplicated urinary tract infection: helps eradicate causative bacteria and relieve symptoms. - Recurrent urinary tract infection prophylaxis: reduces the frequency of infection episodes when taken regularly. - Travelers' diarrhea caused by susceptible bacteria: may be used as part of combination therapy to treat acute diarrheal illness.

Trimethoprim may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and rare events.

Common Side Effects: - Nausea or vomiting. - Loss of appetite. - Mild diarrhea. - Headache. - Skin rash or itching. - Mild dizziness.

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Blood dyscrasias including agranulocytosis, aplastic anemia, or leukopenia. - Hepatotoxicity or elevated liver enzymes. - Acute kidney injury or interstitial nephritis. - Hyperkalemia, especially when combined with other potassium‑sparing agents.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

- Renal function: assess and adjust dosing in severe renal impairment. - Hepatic function: monitor liver enzymes during prolonged therapy. - Pregnancy: use only if clearly needed after risk‑benefit assessment. - Breastfeeding: caution, as drug may be excreted in milk. - Drug interactions: review concomitant medications for additive effects. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Trimethoprim can affect the pharmacokinetics or pharmacodynamics of several medicines. Interactions are grouped by clinical significance.

Major Interactions (Avoid): - Methotrexate: increased toxicity due to additive folate antagonism. - Warfarin: enhanced anticoagulant effect, raising bleeding risk. - Phenytoin: reduced efficacy of trimethoprim, potentially leading to treatment failure.

Moderate Interactions (Monitor Closely): - Loop diuretics: heightened risk of hyperkalemia. - ACE inhibitors or ARBs: additive effect on serum potassium levels. - Sulfonamides: combined folate antagonism may increase toxicity. - Oral contraceptives: possible reduction in contraceptive effectiveness.